Oversee the scientific direction, planning and execution of the CARTAI project, ensuring alignment with grant objectives and timelines.
Coordinate experimental work across multiple domains, including genetic engineering, CAR-T construct development and cell-based functional assays (including cytotoxicity and avidity studies).
Lead scientific troubleshooting, data interpretation and decision making across project stages.
Ensure high quality reporting, documentation, and compliance with grant requirements and internal QA standards.
Guide the design, generation and optimization of CAR constructs, including scFv engineering, promoter/element selection and lentiviral vector strategies.
Supervise or perform laboratory work related to:
Genetic modification of T cells and reporter lines.
High-throughput selection of CAR variants (fluorescent reporter assays, library screening)
In vitro cytotoxicity, binding/avidity assays, and kinetic functional testing of CAR-T cells.
Transduction, expansion and characterization of primary human T cells.
Integration and interpretation of AI/ML derived CAR sequence predictions together with wet lab results in collaboration with AI team.
Act as the main scientific point of contact for internal stakeholders, project managers and senior leadership.
Collaborate with computational biology, machine learning, in vitro pharmacology, HTS, and in vivo teams to ensure seamless execution of complex workflows.
Contribute to scientific communication, risk mitigation, publication planning and preparation of future grant extensions.
Wymagania
PhD in molecular biology, immunology, biotechnology, gene therapy, or related field with 2+ years of postdoctoral/industry experience.